CVRx® Launches HOPE4HF™ Clinical Trial Evaluating Barostim neo™ in Heart ... Sacramento Bee The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients. Dr. Richard Abben, Director of Cardiac Intervention, with the Cardiovascular Institute of the South, in Houma, Louisiana is the Principal ... |
